initial implanter (26% vs 11%, p¼0.004), and when reoperation was performed by a high volume implanter (p<0.001). On multivariate analysis, salvage was less common when the operation for infection was not performed by the original implanter (OR 0.42, p¼0.04) or was performed by a low volume implanter ( 2/year vs >20/year, OR 0.21, p¼0.01).
INTRODUCTION AND OBJECTIVES:
Prescribing oral antibiotics following IPP implantation is common practice; however, the impact of oral antibiotics on device infection and explantation is unknown. We sought to identify risk factors associated with device explantation in a prospective national database focusing on the role of outpatient oral antibiotics.
METHODS: Using MarketScan, we identified men who underwent IPP placement from 2003-2014 and their associated clinical and demographic data. The primary endpoint was subsequent device explantation as determined by IPP removal CPT codes. Multivariate analysis assessed the effect of comorbidity and outpatient oral antibiotics on device explantation.
RESULTS: 10,847 men underwent IPP placement, with 228 (2.1%) undergoing subsequent explantation at a median of 42 days postoperatively . Postoperative oral antibiotics were prescribed following 6528 cases (60.6%). Patients with diabetes, higher Charlson comorbidity index (CCI) and history of prior IPP incurred higher rates of explantation, whereas rates did not differ in men receiving postoperative oral antibiotics (Table 1) . On multivariate analysis, diabetes, CCI greater than 2 and prior IPP placement were all associated with increased odds of explantation (p<0.05). Postoperative oral antibiotics did not decrease the odds of explantation and trended towards harm (OR 1.27, 95% CI 0.96-1.68). Among the subset of patients with preoperative intravenous antibiotic data (3008), a regimen consistent with AUA guidelines was administered in 2006 (66.7%). Rate of explantation was lower in patients who received an AUA-recommended antibiotic regimen, although the difference was not significant (1.4 vs 2.3%, p¼0.07). However, significantly lower explant rates were experienced by men receiving an aminoglycoside (1.4 vs 2.6%, p¼0.04).
CONCLUSIONS: This review of a prospectively maintained national database did not demonstrate a benefit for postoperative oral antibiotics following IPP. Although this may be related to unmeasured risk factors prompting use of oral antibiotics, it suggests that routine use may be unnecessary and potentially detrimental. In contrast, perioperative intravenous aminoglycoside use is one modifiable factor that may reduce the risk of explantation.
Source of Funding: University of Chicago Institute for Translational Medicine

MP25-16 PENILE REVASCULARIZATION SURGERY IN PATIENTS WITH DIABETIC ERECTILE DYSFUNCTION : LONG TERM RESUTS
Onder Kayigil*, Emrah Okulu, Ankara, Turkey; Fatih Akdemir, Samsun, Turkey INTRODUCTION AND OBJECTIVES: To determine the overall long-term success of penile revascularization surgery in the treatment of vasculogenic erectile dysfunction and also to investigate the effect of risk factors on the results of a modified Furlow-Fisher technique.We completed our revascularization surgery results in our 50 erectile dysfunction patients having no risk factors except diabetes with a long term follow-up.
METHODS: Between 2004 and 2015,225 patients with a mean age of 47.2(range:23e73) years underwent penile revascularization surgery.Among them, 50 patients were diagnosed as having diabetes mellitus and completed the mean 60,94AE1,34 months follow-up.All the patients were routinely interviewed in the Departments of internal Medicine,Neurology,Psychiatry,and Anaesthesiology.Preoperative urological evaluation was performed with penile colour Doppler ultrasonography,corpus cavernosum electromyography(CC-EMG) and cavernosometry.At least five points of increase in the IIEF-5 score during the latest patient visit in the postoperative period compared with the preoperative period was regarded as improvement(surgical success).
RESULTS: The mean total IIEF score was 28.1AE5.7 before surgery,and it was 42.2AE6.3 at the end of the follow-up(P<0.05).The mean IIEF-5 score was 8.3AE2.2 before surgery,and it was 17.7AE2.1 at the end of the follow-up(P<0.05).Before surgery, the mean Erectile Function-domain score was 11.6AE3.4,and it was 21.7AE6.1 at the end of the follow-up(P<0.05).According to the IIEF-15,32 e316 THE JOURNAL OF UROLOGY â Vol. 197, No. 4S, Supplement, Saturday, May 13, 2017 
